A new neural network claims to outperform existing models at spotting multiple neurological conditions from a single MRI scan.
Researchers introduced End-Net, a 24-layer convolutional network built around 21 inception modules that pull features at multiple scales simultaneously. The model was tested on MRI scans covering Alzheimer's disease, brain tumors, multiple sclerosis, and healthy controls. Because the dataset skewed heavily toward some conditions, the team used a generative adversarial technique to synthesize additional examples of rarer cases and trimmed the overrepresented ones. End-Net was then wrapped into a web interface for real-time inference.
Most MRI classification networks are designed to answer one yes-or-no question - tumor or no tumor - not to distinguish several conditions at once. A system that handles all four categories in one pass is more clinically useful, provided accuracy holds up outside a controlled dataset, which peer review will need to scrutinize. The web deployment piece is notable because researchers rarely take that last step, though it also raises obvious questions about clinical validation and regulatory clearance.
A model that outperforms benchmarks on a curated dataset is a long way from a tool a neurologist trusts in practice - but as proofs of concept go, this one at least ships something you can click.